EBV-associated lymphomas in adults

Best Practice and Research: Clinical Haematology

Volumn 25, Issue 1, 2012, Pages 75-89

  Roschewski, Mark ^a   Wilson, Wyndham H ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

cytotoxic T lymphocyte; EBNA 1; Epstein Barr virus; LMP 1; lymphoma; lymphoproliferative disorders

Indexed keywords

ALEMTUZUMAB; ALPHA2B INTERFERON; ASPARAGINASE; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; EPSTEIN BARR VIRUS ANTIGEN 1; ETOPOSIDE; IFOSFAMIDE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; RITUXIMAB; VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS PATIENT; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; B CELL LYMPHOMA; BONE MARROW SUPPRESSION; BURKITT LYMPHOMA; CARCINOGENESIS; DISEASE ASSOCIATION; DRUG DOSE ESCALATION; EPSTEIN BARR VIRUS INFECTION; HEMATOPOIETIC STEM CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IATROGENIC DISEASE; IN VITRO STUDY; LARGE CELL LYMPHOMA; LYMPHOMA; LYMPHOMATOID GRANULOMATOSIS; LYMPHOPROLIFERATIVE DISEASE; MORBIDITY; MORTALITY; NK T CELL LYMPHOMA; ORGAN TRANSPLANTATION; PERIPHERAL T CELL LYMPHOMA; PLASMABLASTIC LYMPHOMA; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PYOTHORAX ASSOCIATED LYMPHOMA; RANDOMIZED CONTROLLED TRIAL (TOPIC); VIRUS LATENCY;

EID: 84858319300     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2012.01.005     Document Type: Review

References (95)

1. J.I. Cohen Epstein-Barr virus infection N Engl J Med 343 2000 481 492 (Pubitemid 30646489)
2. S.H.C.E. Swerdlow, N.L. Harris, and E.S. Jaffe WHO classification of tumours of haematopoeitic and lymphoid tissues 4th ed. 2008 International Agency for Research on Cancer (IARC) Lyon, France
3. D.A. Thorley-Lawson, and A. Gross Persistence of the Epstein-Barr virus and the origins of associated lymphomas N Engl J Med 350 2004 1328 1337 (Pubitemid 38375368)
4. L.S. Young, and P.G. Murray Epstein-Barr virus and oncogenesis: from latent genes to tumours Oncogene 22 2003 5108 5121 (Pubitemid 37059592)
5. A. Saha, and E.S. Robertson Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes Clin Cancer Res 17 2011 3056 3063
6. M.A. Epstein, and Y.M. Barr Cultivation in vitro of human lymphoblasts from Burkitt's malignant lymphoma Lancet 1 1964 252 253
7. W. Kulwichit, R.H. Edwards, and E.M. Davenport Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice Proc Natl Acad Sci U S A 95 1998 11963 11968 (Pubitemid 28460522)
8. J. Uchida, T. Yasui, and Y. Takaoka-Shichijo Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses Science 286 1999 300 303 (Pubitemid 29484694)
9. M. Vaysberg, S.L. Lambert, and S.M. Krams Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma Am J Transplant 9 2009 2292 2302
10. M.M. Brinkmann, and T.F. Schulz Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae J Gen Virol 87 2006 1047 1074
11. X. Zhang, D. Sanmun, and L. Hu Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways Biochem Biophys Res Commun 360 2007 263 268 (Pubitemid 46990352)
12. D. Xu, L. Zhao, and L. Del Valle Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes J Virol 82 2008 6251 6258 (Pubitemid 351875106)
13. K. Vrzalikova, M. Vockerodt, and S. Leonard Down-regulation of BLIMP1alpha by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas Blood 117 2011 5907 5917
14. T.F. Schulz, and S. Cordes Is the Epstein-Barr virus EBNA-1 protein an oncogen? Proc Natl Acad Sci U S A 106 2009 2091 2092
15. L. Giulino, S. Mathew, and G. Ballon A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma Blood 117 2011 4852 4854
16. S.A. Kamranvar, B. Gruhne, and A. Szeles Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma Oncogene 26 2007 5115 5123 (Pubitemid 47206955)
17. S.A. Kamranvar, and M.G. Masucci The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress Leukemia 25 2011 1017 1025
18. M.L. Gulley, M. Raphael, and C.T. Lutz Epstein-Barr virus integration in human lymphomas and lymphoid cell lines Cancer 70 1992 185 191
19. N. Shimizu, A. Tanabe-Tochikura, and Y. Kuroiwa Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV J Virol 68 1994 6069 6073
20. J. Komano, M. Sugiura, and K. Takada Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata J Virol 72 1998 9150 9156 (Pubitemid 28471860)
21. G.L. Kelly, A.E. Milner, and G.S. Baldwin Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells Proc Natl Acad Sci U S A 103 2006 14935 14940 (Pubitemid 44527832)
22. A. Chene, D. Donati, and J. Orem Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus Semin Cancer Biol 19 2009 411 420
23. I. Magrath, M. Adde, and A. Shad Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen J Clin Oncol 14 1996 925 934 (Pubitemid 26085538)
24. D.A. Thomas, S. Faderl, and S. O'Brien Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia Cancer 106 2006 1569 1580
25. K. Aozasa Pyothorax-associated lymphoma J Clin Exp Hematop 46 2006 5 10
26. M. Fukayama, T. Ibuka, and Y. Hayashi Epstein-Barr virus in pyothorax-associated pleural lymphoma Am J Pathol 143 1993 1044 1049 (Pubitemid 24070546)
27. S. Nakatsuka, M. Yao, and Y. Hoshida Pyothorax-associated lymphoma: a review of 106 cases J Clin Oncol 20 2002 4255 4260 (Pubitemid 35191029)
28. H. Kanno, N. Naka, and Y. Yasunaga Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma: possible role in the development of overt lymphoma in immunocompetent hosts Am J Pathol 150 1997 349 357 (Pubitemid 27027124)
29. T. Takakuwa, K. Tresnasari, and N. Rahadiani Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein-Barr virus infection Leukemia 22 2008 620 627 (Pubitemid 351386733)
30. T. Oyama, K. Ichimura, and R. Suzuki Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients Am J Surg Pathol 27 2003 16 26 (Pubitemid 36014895)
31. Y. Shimoyama, T. Oyama, and N. Asano Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review J Clin Exp Hematop 46 2006 1 4
32. T. Oyama, K. Yamamoto, and N. Asano Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients Clin Cancer Res 13 2007 5124 5132 (Pubitemid 47502080)
33. S.D. Dojcinov, G. Venkataraman, and S. Pittaluga Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma Blood 117 2011 4726 4735
34. N. Asano, K. Yamamoto, and J. Tamaru Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients Blood 113 2009 2629 2636
35. S. Park, J. Lee, and Y.H. Ko The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma Blood 110 2007 972 978 (Pubitemid 47267436)
36. N. Munoz, R.J. Davidson, and B. Witthoff Infectious mononucleosis and Hodgkin's disease Int J Cancer 22 1978 10 13 (Pubitemid 8368862)
37. P.H. Levine, D.V. Ablashi, and C.W. Berard Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease Cancer 27 1971 416 421
38. L.M. Weiss, L.A. Movahed, and R.A. Warnke Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease N Engl J Med 320 1989 502 506 (Pubitemid 19062526)
39. R. Kuppers The biology of Hodgkin's lymphoma Nat Rev Cancer 9 2009 15 27
40. M.P. Thompson, and R. Kurzrock Epstein-Barr virus and cancer Clin Cancer Res 10 2004 803 821 (Pubitemid 38198878)
41. C. Steidl, T. Lee, and S.P. Shah Tumor-associated macrophages and survival in classic Hodgkin's lymphoma N Engl J Med 362 2010 875 885
42. S. Hohaus, R. Santangelo, and M. Giachelia The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma Clin Cancer Res 17 2011 2885 2892
43. W.H. Wilson, D.W. Kingma, and M. Raffeld Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b Blood 87 1996 4531 4537 (Pubitemid 26162358)
44. A.L. Katzenstein, and S.C. Peiper Detection of Epstein-Barr virus genomes in lymphomatoid granulomatosis: analysis of 29 cases by the polymerase chain reaction technique Mod Pathol 3 1990 435 441
45. E.S. Jaffe, and W.H. Wilson Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications Cancer Surv 30 1997 233 248 (Pubitemid 27371545)
46. G. Frizzera, E.M. Moran, and H. Rappaport Angio-immunoblastic lymphadenopathy with dysproteinaemia Lancet 1 1974 1070 1073
47. I. Anagnostopoulos, M. Hummel, and T. Finn Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type Blood 80 1992 1804 1812
48. A. Dogan, A.D. Attygalle, and C. Kyriakou Angioimmunoblastic T-cell lymphoma Br J Haematol 121 2003 681 691 (Pubitemid 36718184)
49. J. Vose, J. Armitage, and D. Weisenburger International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes J Clin Oncol 26 2008 4124 4130
50. A.A. Alizadeh, and R.H. Advani Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies Clin Adv Hematol Oncol 6 2008 899 909
51. Y. Zhou, A.D. Attygalle, and S.S. Chuang Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load Br J Haematol 138 2007 44 53 (Pubitemid 46889786)
52. K. Dunleavy, W.H. Wilson, and E.S. Jaffe Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications Curr Opin Hematol 14 2007 348 353 (Pubitemid 46842809)
53. R. Advani, S. Horwitz, and A. Zelenetz Angioimmunoblastic T cell lymphoma: treatment experience with cyclosporine Leuk Lymphoma 48 2007 521 525 (Pubitemid 46487759)
54. G. Gualco, P. Domeny-Duarte, and L. Chioato Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis Am J Surg Pathol 35 2011 1195 1203
55. W.Y. Au, A. Pang, and C. Choy Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients Blood 104 2004 243 249 (Pubitemid 38879864)
56. A. Jaccard, N. Gachard, and B. Marin Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study Blood 117 2011 1834 1839
57. A. Jaccard, and O. Hermine Extranodal natural killer/T-cell lymphoma: advances in the management Curr Opin Oncol 23 2011 429 435
58. D. Ennishi, Y. Maeda, and N. Fujii Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type Leuk Lymphoma 52 2011 1255 1261
59. A.M. Evens, R. Roy, and D. Sterrenberg Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy Curr Oncol Rep 12 2010 383 394
60. C.V. Paya, J.J. Fung, and M.A. Nalesnik Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and the Mayo Clinic Organized International Consensus development meeting Transplantation 68 1999 1517 1525
61. H.Y. Draoua, L. Tsao, and D.M. Mancini T-cell post-transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience Br J Haematol 127 2004 429 432 (Pubitemid 39536595)
62. B.P. Nelson, M.A. Nalesnik, and D.W. Bahler Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol 24 2000 375 385 (Pubitemid 30127473)
63. J. Mautner, and G.W. Bornkamm The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection Eur J Cell Biol 2011
64. O. Landgren, E.S. Gilbert, and J.D. Rizzo Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation Blood 113 2009 4992 5001
65. Z. Peric, X. Cahu, and P. Chevallier Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation Leukemia 25 2011 932 938
66. J.P. Nourse, K. Jones, and M.K. Gandhi Epstein-Barr virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy Am J Transplant 11 2011 888 895
67. C.D. DiNardo, and D.E. Tsai Treatment advances in posttransplant lymphoproliferative disease Curr Opin Hematol 17 2010 368 374
68. R.F. Ambinder Epstein-Barr virus associated lymphoproliferations in the AIDS setting Eur J Cancer 37 2001 1209 1216 (Pubitemid 32553766)
69. S. Camilleri-Broet, F. Davi, and J. Feuillard High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas Blood 86 1995 432 435
70. A. Cingolani, R. Gastaldi, and L. Fassone Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas J Clin Oncol 18 2000 3325 3330
71. S. Bayraktar, U.D. Bayraktar, and J.C. Ramos Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors J Neurooncol 101 2011 257 265
72. M. Deckert, A. Engert, and W. Bruck Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma Leukemia 2011
73. L. Fassone, K. Bhatia, and M. Gutierrez Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma Leukemia 14 2000 271 277 (Pubitemid 30095382)
74. R.G. Nador, E. Cesarman, and A. Chadburn Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus Blood 88 1996 645 656 (Pubitemid 26240396)
75. D. Roy, S.H. Sin, and B. Damania Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines Blood 118 2011 e32 e39
76. H.J. Delecluse, I. Anagnostopoulos, and F. Dallenbach Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection Blood 89 1997 1413 1420 (Pubitemid 27080006)
77. L. Colomo, F. Loong, and S. Rives Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities Am J Surg Pathol 28 2004 736 747 (Pubitemid 38685887)
78. A. Valera, O. Balague, and L. Colomo IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas Am J Surg Pathol 34 2010 1686 1694
79. N. Mounier, M. Spina, and J.P. Spano Hodgkin lymphoma in HIV positive patients Curr HIV Res 8 2010 141 146
80. R. Dolcetti, M. Boiocchi, and A. Gloghini Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease Eur J Cancer 37 2001 1276 1287 (Pubitemid 32553772)
81. P. Hartmann, U. Rehwald, and B. Salzberger BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection Ann Oncol 14 2003 1562 1569 (Pubitemid 37304614)
82. P. Hartmann, U. Rehwald, and B. Salzberger Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection Expert Rev Anticancer Ther 4 2004 401 410 (Pubitemid 38745112)
83. E. Baecklund, C. Sundstrom, and A. Ekbom Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma Arthritis Rheum 48 2003 1543 1550 (Pubitemid 36682361)
84. M.F. Callan Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients Curr Opin Rheumatol 16 2004 399 405 (Pubitemid 38803141)
85. F. Wolfe, and K. Michaud Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study Arthritis Rheum 56 2007 2886 2895 (Pubitemid 47502734)
86. O.W. Kamel, M. van de Rijn, and L.M. Weiss Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis N Engl J Med 328 1993 1317 1321 (Pubitemid 23131374)
87. R.J. O'Reilly, T.N. Small, and E. Papadopoulos Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts Immunol Rev 157 1997 195 216 (Pubitemid 27303130)
88. E.B. Papadopoulos, M. Ladanyi, and D. Emanuel Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation N Engl J Med 330 1994 1185 1191 (Pubitemid 24121987)
89. C.M. Rooney, C.A. Smith, and C.Y. Ng Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation Lancet 345 1995 9 13
90. H.E. Heslop, K.S. Slobod, and M.A. Pule Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients Blood 115 2010 925 935
91. C. Munz, K.L. Bickham, and M. Subklewe Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1 J Exp Med 191 2000 1649 1660 (Pubitemid 30331564)
92. M.A. Roskrow, N. Suzuki, and Y. Gan Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease Blood 91 1998 2925 2934 (Pubitemid 28227543)
93. C.M. Bollard, L. Aguilar, and K.C. Straathof Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease J Exp Med 200 2004 1623 1633 (Pubitemid 40094186)
94. C.M. Bollard, S. Gottschalk, and A.M. Leen Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer Blood 110 2007 2838 2845 (Pubitemid 350006936)
95. J.A. Shafer, C.R. Cruz, and A.M. Leen Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma Leuk Lymphoma 51 2010 870 880